1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Delirium Global Clinical Trials Review, H1, 2016

Delirium Global Clinical Trials Review, H1, 2016

  • March 2016
  • -
  • Global Data
  • -
  • 145 pages

Delirium Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, H1, 2016" provides an overview of Delirium clinical trials scenario. This report provides top line data relating to the clinical trials on Delirium. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Delirium Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Delirium to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Delirium to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Delirium Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 142
Abbreviations 142
Definitions 142
Research Methodology 143
Secondary Research 143
About GlobalData 144
Contact Us 144
Disclaimer 144
Source 145

List of Tables
Delirium Therapeutics, Global, Clinical Trials by Region, 2016* 6
Delirium Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Delirium Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Delirium Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Delirium Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Delirium Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Delirium Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Delirium Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Delirium to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Delirium Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Delirium Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Delirium to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18
Delirium Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Delirium Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Delirium Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Delirium Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Delirium Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Delirium Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Delirium Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Delirium Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Delirium Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Delirium Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Delirium Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31

List of Figures
Delirium Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Delirium Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Delirium Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Delirium Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Delirium Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Delirium Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Delirium Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Proportion of Delirium to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Delirium Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Delirium Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Delirium to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18
Delirium Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Delirium Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Delirium Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Delirium Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Delirium Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Delirium Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Delirium Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Delirium Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Delirium Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Delirium Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Delirium Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 143

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

Global and Chinese Paliperidone Palmitate (CAS 199739-10-1) Industry, 2017 Market Research Report

Global and Chinese Paliperidone Palmitate (CAS 199739-10-1) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Paliperidone Palmitate Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Paliperidone Palmitate industry with a ...

Global and Chinese Levosulpiride (CAS 23672-07-3) Industry, 2017 Market Research Report

Global and Chinese Levosulpiride (CAS 23672-07-3) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Levosulpiride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Levosulpiride industry with a focus on the Chinese ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • February 2017
    12 pages
  • Therapy  

  • United Kingdom  

View report >

Therapy Market in the US

  • February 2017
    254 pages
  • Therapy  

    Anti-Infective  

    Hormone  

  • United States  

View report >

Antipsychotic Market in Australia - Forecast

  • January 2017
    2 pages
  • Antipsychotic  

    Lithium  

  • Australia  

    Oceania  

    Canada  

View report >

Antipsychotic Market

2 months ago

Related Market Segments :

Antipsychotic
Therapy
Hormone
Anesthetics
Opioid

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.